IGHE and allergic respiratory disease: A good characterization of patients’ IgE reactivities including determination of cross-reactive allergens may also represent a first step towards the development of new immunotherapeutic strategies for CMA similar to those that are developed based on recombinant allergens for respiratory allergies [144,150,154,166].